PhoreMost, NeoPhore secure Innovate UK funding for small-molecule cancer immunotherapy programPharmaceutical Business ReviewThe companies are partners on a grant titled, "A novel small molecule approach to enhance cancer immunotherapy." Their… Continue reading
Yahoo NewsCan ExxonMobil Use Synthetic Biology to Commercialize Algae Fuels?Yahoo NewsWe have fossil fuels today because a bunch of algae and other biomass sank to the bottom of dinosaur-laden swamps tens of millions of years ago, where it was compress… Continue reading
Motley FoolCan ExxonMobil Use Synthetic Biology to Commercialize Algae Fuels?Motley FoolWe have fossil fuels today because a bunch of algae and other biomass sank to the bottom of dinosaur-laden swamps tens of millions of years ago, where it was compre… Continue reading
IAM (blog) |
CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences
IAM (blog) With news of the US Supreme Court’s recent Oil States decision and the UK’s ratification of the Unified Patent Court Agreement capturing the headlines in recent days, patent professionals might be forgiven for allowing a crucial CRISPR-Cas9 dispute to … |
Animal Pharm |
Panion begins gene therapy safety study in dogs
Animal Pharm Swedish firm Panion Animal Health has started a safety study for its canine gene therapy candidate at the University of Copenhagen in Denmark. Already a subscriber? Please sign in below to continue reading. Sign In. Thanks, we’ve sent a link to reset … |